Oct 23 (Reuters) - PYC Therapeutics Ltd (PYC) :
- PYC THERAPEUTICS GETS FDA RESPONSE ON ORPHAN DRUG DESIGNATION REQUEST
- FDA SEEKS DATA ON CO'S LEAD DRUG VP-001
- DATA ASKED FOR DRUG'S USE IN ANIMAL MODEL OF RP/RETINAL DYSTROPHY DUE TO PRPF31 MUTATIONS OR IN PATIENTS BEFORE CONSIDERING REQUEST
News: PYC PYC Therapeutics Gets FDA Response On Orphan Drug Designation Request
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
-0.025(1.89%) |
Mkt cap ! $755.3M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.32 | $1.30 | $478.1K | 365.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |